Your browser doesn't support javascript.
loading
Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial.
Majhail, Navneet S; Miller, Beckley; Dean, Rebecca; Manghani, Rocio; Shin, Heayoung; Sivaraman, Smitha; Maziarz, Richard T.
Afiliación
  • Majhail NS; Sarah Cannon Transplant and Cellular Therapy Network, Nashville, Tennessee. Electronic address: navneet.majhail@sarahcannon.com.
  • Miller B; PRECISIONheor, Boston, Massachusetts.
  • Dean R; PRECISIONheor, Boston, Massachusetts.
  • Manghani R; Gamida Cell, Ltd, Boston, Massachusetts.
  • Shin H; Gamida Cell, Ltd, Boston, Massachusetts.
  • Sivaraman S; Gamida Cell, Ltd, Boston, Massachusetts.
  • Maziarz RT; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Transplant Cell Ther ; 29(12): 749.e1-749.e5, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37703995
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Trasplante de Células Madre de Sangre del Cordón Umbilical Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Trasplante de Células Madre de Sangre del Cordón Umbilical Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article